A tweaked virus that invades malignant cells has allowed patients with advanced liver cancer to survive for months longer than usual. Scientists report online February 10 in
Nature Medicine that the virus can sabotage tumors and expose them to attack by the immune system.
The virus-based treatment will add a new weapon to medicine’s armory of tumor killers, says Ulrich Lauer, a hepatologist at the University of Tübingen in Germany, who
wasn’t involved in the research.
Log in
Subscribers, enter your e-mail address for full access to the Science News archives and digital editions.